Rare Diseases Weekly News - September 11th 2025
🧬 This Week in Rare Diseases: Servier Fragile X deal, FDA RDEP, Bylvay Canada…
The Next Frontier: Pharma and Longevity
From The Epic of Gilgamesh, the earliest surviving book, to the controversial…
How a top-20 Pharma company gained competitive intelligence to formulate its market access strategy in the antibiotics market in Taiwan
The Challenge: Finding out the key competitor’s launch plan A Top-20 Pharma…
How we helped a large-size Pharma prepare its sales and medical teams to beat a competitor launch of a new schizophrenia medication.
The Challenge: Gaining insights into competitor's new schizophrenia medication…
How we helped a Pharma in the migraine space enhance its online presence and online KOL engagement.
The Challenge: Gaining competitive intelligence in the migraine space from…
How we contributed to our client's marketing strategy so that they succeed in the ever-evolving Atopic Dermatitis landscape.
The challenge: Being in the loop in the Atopic Dermatitis landscape A Top-10…
How we helped a major pharma identify and monitor existing and new Gx EU competitors and settle specific court actions with few of them.
The challenge: Identifying and monitoring current and potential competitors and…
Some thoughts on the exciting times ahead for AIDS / HIV treatment
Despite >37m people currently living with #HIV, the significant progress…
